- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Routine Mammography Not Necessary in Addition to Routine MRI
Routine mammography does not detect more cancers among high-risk women who undergo annual screening with MRI.
Adding screening mammography to annual screening MR imaging for women at high risk for breast cancer does not increase cancer detection rates, according to a study published in Radiology.
Researchers from Canada performed a retrospective review to evaluate the value of mammography in detecting breast cancer in high-risk women undergoing screening breast MR imaging.
The researchers evaluated 3,934 screening studies (1,977 screening MR imaging examinations and 1,957 screening mammograms) performed in 1,249 high-risk women. The performance measures included recall and cancer detection rates, sensitivity, specificity, and positive predictive values were calculated for both mammography and MR imaging.
The results showed a total of 45 cancers (33 invasive and 12 ductal carcinomas in situ) were diagnosed. Forty-three were seen with MR imaging and 14 with both mammography and MR imaging.
The researchers concluded that contemporaneous screening mammography did not add value in detection of breast cancer for women who undergo screening MR imaging. Routine use of screening mammography in women undergoing screening breast MR imaging warrants reconsideration, they wrote.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
